This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million
Last Update:
18 5 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.